Today, Israel Chemicals Ltd. (ICL) Releases Quarterly Earnings Results, Meets Expectations

Today, Israel Chemicals Ltd. (ICL) Releases Quarterly  Earnings Results, Meets Expectations
Israel Chemicals Ltd. (NYSE:ICL) issued its earnings results on Wednesday. The company reported $0.09 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.09. The business earned $1.38 billion during the quarter. Israel Chemicals had a return on equity of 17.44% and a net margin of 7.40%. The business’s quarterly revenue was up .3% on a year-over-year basis. During the same period last year, the business earned $0.12 EPS.

Israel Chemicals (NYSE:ICL) traded down 2.63% during mid-day trading on Friday, reaching $3.70. The company had a trading volume of 38,070 shares. The stock has a market cap of $4.71 billion, a PE ratio of 11.67 and a beta of 1.14. The firm’s 50-day moving average price is $3.74 and its 200-day moving average price is $3.99. Israel Chemicals has a 12 month low of $3.52 and a 12 month high of $5.23.

Several hedge funds have recently bought and sold shares of the company. Public Sector Pension Investment Board raised its stake in Israel Chemicals by 19.0% in the second quarter. Public Sector Pension Investment Board now owns 96,656 shares of the company’s stock valued at $374,000 after buying an additional 15,400 shares in the last quarter. Alliancebernstein L.P. raised its stake in Israel Chemicals by 1.6% in the second quarter. Alliancebernstein L.P. now owns 496,495 shares of the company’s stock valued at $1,936,000 after buying an additional 7,874 shares in the last quarter. Canada Pension Plan Investment Board raised its stake in Israel Chemicals by 20.2% in the second quarter. Canada Pension Plan Investment Board now owns 1,788,370 shares of the company’s stock valued at $6,929,000 after buying an additional 300,800 shares in the last quarter. Commonwealth Bank of Australia raised its stake in Israel Chemicals by 17.1% in the second quarter. Commonwealth Bank of Australia now owns 322,971 shares of the company’s stock valued at $1,251,000 after buying an additional 47,189 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in Israel Chemicals by 1.5% in the second quarter. Vanguard Group Inc. now owns 8,841,883 shares of the company’s stock valued at $34,484,000 after buying an additional 131,595 shares in the last quarter. Institutional investors and hedge funds own 6.51% of the company’s stock.

Separately, Zacks Investment Research raised Israel Chemicals from a “hold” rating to a “buy” rating and set a $4.25 target price for the company in a research report on Monday.

Related posts

Leave a Comment